{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:48:43Z","timestamp":1791233323944,"version":"4.1.0"},"reference-count":38,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej17-0026","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T17:05:06Z","timestamp":1485968706000},"page":"237-244","source":"Crossref","is-referenced-by-count":102,"title":["Natural history of thyroid cancer [Review]"],"prefix":"10.1507","volume":"64","author":[{"given":"Toru","family":"Takano","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. <i>Nat Rev Cancer<\/i> 6: 292-306.","DOI":"10.1038\/nrc1836"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nikiforov YE, Nikiforova MN (2011) Molecular genetics and diagnosis of thyroid cancer. <i>Nat Rev Endocrinol<\/i> 7: 569-580.","DOI":"10.1038\/nrendo.2011.142"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Frazell EL, Foote FW Jr (1949) The natural history of thyroid cancer; a review of 301 cases. <i>J Clin Endocrinol Metab<\/i> 9: 1023-1030.","DOI":"10.1210\/jcem-9-10-1023"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Burn JI, Taylor SF (1962) Natural history of thyroid carcinoma. A study of 152 treated patients. <i>Br Med J<\/i> 2: 1218-1223.","DOI":"10.1136\/bmj.2.5314.1218"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ahn HS, Kim HJ, Welch HG (2014) Korea&rsquo;s thyroid-cancer &ldquo;epidemic&rdquo;--screening and overdiagnosis. <i>N Engl J Med<\/i> 371: 1765-1767.","DOI":"10.1056\/NEJMp1409841"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ahn HS, Welch HG (2015) South Korea&rsquo;s Thyroid-Cancer &ldquo;Epidemic&rdquo;--Turning the Tide. <i>N Engl J Med<\/i> 373: 2389-2390.","DOI":"10.1056\/NEJMc1507622"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, <i>et al<\/i>. (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. <i>Ann Surg<\/i> 237: 399-407.","DOI":"10.1097\/01.SLA.0000055273.58908.19"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Suzuki S (2016) Childhood and adolescent thyroid cancer in Fukushima after the Fukushima Daiichi nuclear power plant accident: 5 years on. <i>Clin Oncol (R Coll Radiol) <\/i>28: 263-271.","DOI":"10.1016\/j.clon.2015.12.027"},{"key":"9","unstructured":"9. Nikiforov Y, Gnepp DR, Fagin JA (1996) Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. <i>J Clin Endocrinol Metab<\/i> 81: 9-14."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Holm LE, Dahlqvist I, Israelsson A, Lundell G (1980) Malignant thyroid tumors after iodine-131 therapy: a retrospective cohort study. <i>N Engl J Med<\/i> 303: 188-191.","DOI":"10.1056\/NEJM198007243030404"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, <i>et al<\/i>. (1996) Targeted expression of the ret\/PTC1 oncogene induces papillary thyroid carcinomas. <i>Endocrinology<\/i> 137: 375-378.","DOI":"10.1210\/endo.137.1.8536638"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Charles RP, Iezza G, Amendola E, Dankort D, McMahon M (2011) Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse. <i>Cancer Res<\/i> 71: 3863-3871.","DOI":"10.1158\/0008-5472.CAN-10-4463"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shimamura M, Nakahara M, Orim F, Kurashige T, Mitsutake N, <i>et al<\/i>. (2013) Postnatal expression of BRAFV600E does not induce thyroid cancer in mouse models of thyroid papillary carcinoma. <i>Endocrinology<\/i> 154: 4423-4430.","DOI":"10.1210\/en.2013-1174"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, <i>et al<\/i>. (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. <i>Thyroid<\/i> 24: 27-34.","DOI":"10.1089\/thy.2013.0367"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, <i>et al<\/i>. (2009) Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. <i>Ann Oncol<\/i> 20: 1728-1735.","DOI":"10.1093\/annonc\/mdp050"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Neff RL, Farrar WB, Kloos RT, Burman KD (2008) Anaplastic thyroid cancer. <i>Endocrinol Metab Clin North Am<\/i> 37: 525-538, xi.","DOI":"10.1016\/j.ecl.2008.02.003"},{"key":"17","unstructured":"17. Autopsy database of the Japanese Society of Pathology (http:\/\/pathology.or.jp\/kankoubutu\/JSP-hyou.html)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Williams D (2015) Thyroid growth and cancer. <i>Eur Thyroid J<\/i> 4: 164-173.","DOI":"10.1159\/000437263"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Saad AG, Kumar S, Ron E, Lubin JH, Stanek J, <i>et al<\/i>. (2006) Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. <i>J Clin Endocrinol Metab<\/i> 91: 2672-2677.","DOI":"10.1210\/jc.2006-0417"},{"key":"20","unstructured":"20. Viglietto G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, <i>et al<\/i>. (1995) RET\/PTC oncogene activation is an early event in thyroid carcinogenesis. <i>Oncogene<\/i> 11: 1207-1210."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, <i>et al<\/i>. (1993) High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. <i>J Clin Invest<\/i> 91: 179-184.","DOI":"10.1172\/JCI116168"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, <i>et al<\/i>. (2000) PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. <i>Science<\/i> 289: 1357-1360.","DOI":"10.1126\/science.289.5483.1357"},{"key":"23","unstructured":"23. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, <i>et al<\/i>. (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. <i>Cancer Res<\/i> 63: 1454-1457."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, <i>et al<\/i>. (2003) Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. <i>J Clin Endocrinol Metab<\/i> 88: 4393-4397.","DOI":"10.1210\/jc.2003-030305"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, <i>et al<\/i>. (2005) BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. <i>J Clin Endocrinol Metab<\/i> 90: 6373-6379.","DOI":"10.1210\/jc.2005-0987"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mitsutake N, Fukushima T, Matsuse M, Rogounovitch T, Saenko V, <i>et al<\/i>. (2015) BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl. <i>Sci Rep<\/i> 5: 16976.","DOI":"10.1038\/srep16976"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ito Y, Miyauchi A, Kihara M, Takamura Y, Kobayashi K, <i>et al<\/i>. (2012) Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study. <i>Endocr J<\/i> 59: 399-405.","DOI":"10.1507\/endocrj.EJ12-0044"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kowalski LP, Goncalves Filho J, Pinto CA, Carvalho AL, de Camargo B (2003) Long-term survival rates in young patients with thyroid carcinoma. <i>Arch Otolaryngol Head Neck Surg<\/i> 129: 746-749.","DOI":"10.1001\/archotol.129.7.746"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ito Y, Miyauchi A, Ito M, Yabuta T, Masuoka H, <i>et al<\/i>. (2014) Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapy. <i>Endocr J<\/i> 61: 821-824.","DOI":"10.1507\/endocrj.EJ14-0181"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Takano T, Amino N (2005) Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. <i>Thyroid<\/i> 15: 432-438.","DOI":"10.1089\/thy.2005.15.432"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Takano T (2007) Fetal cell carcinogenesis of the thyroid: theory and practice. <i>Semin Cancer Biol<\/i> 17: 233-240.","DOI":"10.1016\/j.semcancer.2006.02.001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Takano T (2014) Fetal cell carcinogenesis of the thyroid: a modified theory based on recent evidence. <i>Endocr J<\/i> 61: 311-320.","DOI":"10.1507\/endocrj.EJ13-0517"},{"key":"33","unstructured":"33. Takano T (2014) The basic theory of fetal cell carcinogenesis of the thyroid. <i>J Basic Clin Med<\/i> 3: 6-11."},{"key":"34","unstructured":"34. Takano T (2015) Molecular classification of thyroid tumor: A proposal based on fetal cell carcinogenesis hypothesis. <i>J Basic Clin Med<\/i> 4: 81-6."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, <i>et al<\/i>. (2010) Tumorigenic and metastatic activity of human thyroid cancer stem cells. <i>Cancer Res<\/i> 70: 8874-8885.","DOI":"10.1158\/0008-5472.CAN-10-1994"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Mazzaferri EL (2000) Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. <i>Endocr Pract<\/i> 6: 469-476.","DOI":"10.4158\/EP.6.6.469"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. <i>Nature<\/i> 414: 105-111.","DOI":"10.1038\/35102167"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Matsumoto C, Ito M, Yamada H, Yoshida H, Watanabe M, <i>et al<\/i>. (2013) Preparation of thyroid follicular cells for mRNA quantification after fluorescence-activated cell sorting. <i>Scand J Clin Lab Invest<\/i> 73: 245-252.","DOI":"10.3109\/00365513.2013.769624"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/3\/64_EJ17-0026\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T01:14:09Z","timestamp":1568769249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/3\/64_EJ17-0026\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0026","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}